Globeflex Capital’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-69,435
| Closed | -$185K | – | 491 |
|
|
2022
Q1 | $185K | Hold |
69,435
| – | – | 0.04% | 349 |
|
|
2021
Q4 | $301K | Hold |
69,435
| – | – | 0.06% | 322 |
|
|
2021
Q3 | $353K | Sell |
69,435
-46,333
| -40% | -$236K | 0.08% | 277 |
|
|
2021
Q2 | $733K | Buy |
115,768
+121
| +0.1% | +$766 | 0.13% | 242 |
|
|
2021
Q1 | $894K | Buy |
115,647
+46,212
| +67% | +$357K | 0.16% | 205 |
|
|
2020
Q4 | $455K | Hold |
69,435
| – | – | 0.1% | 304 |
|
|
2020
Q3 | $462K | Hold |
69,435
| – | – | 0.12% | 263 |
|
|
2020
Q2 | $578K | Buy |
+69,435
| New | +$578K | 0.15% | 241 |
|
|
2016
Q2 | – | Sell |
-59,000
| Closed | -$761K | – | 465 |
|
|
2016
Q1 | $761K | Buy |
+59,000
| New | +$761K | 0.2% | 171 |
|